+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Central Nervous System Drugs Global Market Report 2019

  • ID: 4721160
  • Report
  • Region: Global
  • 300 pages
  • The Business Research Company
1 of 4

FEATURED COMPANIES

  • Biogen Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc
  • MORE
Central Nervous System Drugs Market Global Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the central nervous system drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Central Nervous System Drugs market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The central nervous system drugs market section of the report gives context. It compares the central nervous system drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, central nervous system drugs indicators comparison.
Scope

Markets Covered: Nervous System Drugs, Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs

Companies Mentioned: Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG

Metrics Covered: Parkinson Prevalence Rate, Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, central nervous system drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Biogen Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc
  • MORE
1. Executive Summary

2. Report Structure

3. Central Nervous System Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Central Nervous System Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Central Nervous System Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Central Nervous System Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Central Nervous System Drugs Market Trends And Strategies

8. Central Nervous System Drugs Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market

9. Central Nervous System Drugs Market Regional Analysis
9.1. Global Central Nervous System Drugs Market, 2018, By Region, Value ($ Billion)
9.2. Global Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Region
9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

10. Central Nervous System Drugs Market Segmentation
10.1. Global Central Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
10.1.1. Nervous System Drugs
10.1.2. Analgesics
10.1.3. Anti-Parkinson drugs
10.1.4. Anesthetics
10.1.5. Anti-Epileptics
10.1.6. Other CNS drugs

11. Central Nervous System Drugs Market Metrics
11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Central Nervous System Drugs Market
12.1. Asia-Pacific Central Nervous System Drugs Market Overview
12.2. Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
12.3. Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
12.4. Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
12.5. Asia-Pacific, Central Nervous System Drugs Market Metrics
12.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
12.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries
12.6. Asia-Pacific Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
12.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
12.7.1. China Central Nervous System Drugs Market
12.7.1.1. China Central Nervous System Drugs Market Overview
12.7.1.2. China Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.1.3. China Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
12.7.1.4. China Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
12.7.2. Australia Central Nervous System Drugs Market
12.7.2.1. Australia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.2.2. Australia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
12.7.2.3. Australia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
12.7.3. Hong Kong Central Nervous System Drugs Market
12.7.3.1. Hong Kong Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.4. India Central Nervous System Drugs Market
12.7.4.1. India Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.4.2. India Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
12.7.4.3. India Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
12.7.5. Indonesia Central Nervous System Drugs Market
12.7.5.1. Indonesia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.6. Japan Central Nervous System Drugs Market
12.7.6.1. Japan Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.6.2. Japan Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
12.7.6.3. Japan Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
12.7.7. Malaysia Central Nervous System Drugs Market
12.7.7.1. Malaysia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.8. New Zealand Central Nervous System Drugs Market
12.7.8.1. New Zealand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.9. Philippines Central Nervous System Drugs Market
12.7.9.1. Philippines Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.10. Singapore Central Nervous System Drugs Market
12.7.10.1. Singapore Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.11. South Korea Central Nervous System Drugs Market
12.7.11.1. South Korea Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.12. Thailand Central Nervous System Drugs Market
12.7.12.1. Thailand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
12.7.13. Vietnam Central Nervous System Drugs Market
12.7.13.1. Vietnam Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Central Nervous System Drugs Market
13.1. Western Europe Central Nervous System Drugs Market Overview
13.2. Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
13.3. Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
13.4. Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
13.5. Western Europe, Central Nervous System Drugs Market Metrics
13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Western Europe Countries
13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries
13.6. Western Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
13.7. Western Europe Central Nervous System Drugs Market: Country Analysis
13.7.1. Austria Central Nervous System Drugs Market
13.7.1.1. Austria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.2. Belgium Central Nervous System Drugs Market
13.7.2.1. Belgium Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.3. Denmark Central Nervous System Drugs Market
13.7.3.1. Denmark Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.4. Finland Central Nervous System Drugs Market
13.7.4.1. Finland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.5. France Central Nervous System Drugs Market
13.7.5.1. France Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.5.2. France Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
13.7.5.3. France Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
13.7.6. Germany Central Nervous System Drugs Market
13.7.6.1. Germany Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.6.2. Germany Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
13.7.6.3. Germany Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
13.7.7. Ireland Central Nervous System Drugs Market
13.7.7.1. Ireland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.8. Italy Central Nervous System Drugs Market
13.7.8.1. Italy Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.8.2. Italy Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
13.7.8.3. Italy Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
13.7.9. Netherlands Central Nervous System Drugs Market
13.7.9.1. Netherlands Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.10. Norway Central Nervous System Drugs Market
13.7.10.1. Norway Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.11. Portugal Central Nervous System Drugs Market
13.7.11.1. Portugal Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.12. Spain Central Nervous System Drugs Market
13.7.12.1. Spain Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.12.2. Spain Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
13.7.12.3. Spain Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
13.7.13. Sweden Central Nervous System Drugs Market
13.7.13.1. Sweden Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.14. Switzerland Central Nervous System Drugs Market
13.7.14.1. Switzerland Central Nervous System Drugs Market2013 - 2022, Value ($ Billion)
13.7.15. UK Central Nervous System Drugs Market
13.7.15.1. UK Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
13.7.15.2. UK Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
13.7.15.3. UK Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Central Nervous System Drugs Market
14.1. Eastern Europe Central Nervous System Drugs Market Overview
14.2. Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
14.3. Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
14.4. Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
14.5. Eastern Europe, Central Nervous System Drugs Market Metrics
14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries
14.6. Eastern Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
14.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis
14.7.1. Czech Republic Central Nervous System Drugs Market,
14.7.1.1. Czech Republic Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
14.7.2. Poland Central Nervous System Drugs Market
14.7.2.1. Poland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
14.7.3. Romania Central Nervous System Drugs Market
14.7.3.1. Romania Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
14.7.4. Russia Central Nervous System Drugs Market
14.7.4.1. Russia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
14.7.4.2. Russia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
14.7.4.3. Russia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Central Nervous System Drugs Market
15.1. North America Central Nervous System Drugs Market Overview
15.2. North America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
15.3. North America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
15.4. North America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
15.5. North America, Central Nervous System Drugs Market Metrics
15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, North America Countries
15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries
15.6. North America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
15.7. North America Central Nervous System Drugs Market: Country Analysis
15.7.1. Canada Central Nervous System Drugs Market
15.7.1.1. Canada Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
15.7.2. Mexico Central Nervous System Drugs Market
15.7.2.1. Mexico Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
15.7.3. USA Central Nervous System Drugs Market
15.7.3.1. USA Central Nervous System Drugs Market Overview
15.7.3.2. USA Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
15.7.3.3. USA Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
15.7.3.4. USA Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Central Nervous System Drugs Market
16.1. South America Central Nervous System Drugs Market Overview
16.2. South America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
16.3. South America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
16.4. South America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
16.5. South America, Central Nervous System Drugs Market Metrics
16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, South America Countries
16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries
16.6. South America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
16.7. South America Central Nervous System Drugs Market: Country Analysis
16.7.1. Argentina Central Nervous System Drugs Market
16.7.1.1. Argentina Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
16.7.2. Brazil Central Nervous System Drugs Market
16.7.2.1. Brazil Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
16.7.2.2. Brazil Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
16.7.2.3. Brazil Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
16.7.3. Chile Central Nervous System Drugs Market
16.7.3.1. Chile Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
16.7.4. Colombia Central Nervous System Drugs Market
16.7.4.1. Colombia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
16.7.5. Peru Central Nervous System Drugs Market
16.7.5.1. Peru Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
16.7.6. Venezuela Central Nervous System Drugs Market
16.7.6.1. Venezuela Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Central Nervous System Drugs Market
17.1. Middle East Central Nervous System Drugs Market Overview
17.2. Middle East, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
17.3. Middle East, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
17.4. Middle East, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
17.5. Middle East, Central Nervous System Drugs Market Metrics
17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Middle East Countries
17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries
17.6. Middle East Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
17.7. Middle East Central Nervous System Drugs Market: Country Analysis
17.7.1. Saudi Arabia Central Nervous System Drugs Market
17.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
17.7.2. Israel Central Nervous System Drugs Market
17.7.2.1. Israel Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
17.7.3. Turkey Central Nervous System Drugs Market
17.7.3.1. Turkey Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
17.7.4. UAE Central Nervous System Drugs Market
17.7.4.1. UAE Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Central Nervous System Drugs Market
18.1. Africa Central Nervous System Drugs Market Overview
18.2. Africa, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
18.3. Africa, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
18.4. Africa, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
18.5. Africa, Central Nervous System Drugs Market Metrics
18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Africa Countries
18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries
18.6. Africa Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
18.7. Africa Central Nervous System Drugs Market: Country Analysis
18.7.1. Egypt Central Nervous System Drugs Market
18.7.1.1. Egypt Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.2. Nigeria Central Nervous System Drugs Market
18.7.2.1. Nigeria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.3. South Africa Central Nervous System Drugs Market
18.7.3.1. South Africa Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

19. Central Nervous System Drugs Market Competitive Landscape
19.1. Competitive Market Overview
19.2. Market Shares
19.3. Company Profiles
19.3.1. Biogen Inc
19.3.1.1. Company Overview
19.3.1.2. Company Central Nervous System Drugs Market Structure And Strategy
19.3.1.3. Company Central Nervous System Drugs Market Products And Services
19.3.1.4. Financial Performance
19.3.2. F. Hoffmann-La Roche Ltd
19.3.2.1. Company Overview
19.3.2.2. Company Central Nervous System Drugs Market Structure And Strategy
19.3.2.3. Company Central Nervous System Drugs Market Products And Services
19.3.2.4. Financial Performance
19.3.3. Johnson & Johnson
19.3.3.1. Company Overview
19.3.3.2. Company Central Nervous System Drugs Market Structure And Strategy
19.3.3.3. Company Central Nervous System Drugs Market Products And Services
19.3.3.4. Financial Performance
19.3.4. Pfizer Inc
19.3.4.1. Company Overview
19.3.4.2. Company Central Nervous System Drugs Market Structure And Strategy
19.3.4.3. Company Central Nervous System Drugs Market Products And Services
19.3.4.4. Financial Performance
19.3.5. Novartis AG
19.3.5.1. Company Overview
19.3.5.2. Company Central Nervous System Drugs Market Structure And Strategy
19.3.5.3. Company Central Nervous System Drugs Market Products And Services
19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

21. Market Background: Pharmaceutical Drugs Market
21.1. Pharmaceutical Drugs Market Characteristics
21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations
22.1. Global Central Nervous System Drugs Market In 2022- Growth Countries
22.2. Global Central Nervous System Drugs Market In 2022- Growth Segments
22.3. Global Central Nervous System Drugs Market In 2022- Growth Strategies

23. Appendix
23.1. NAICS Definitions Of Industry Covered In This Report
23.2. Abbreviations
23.3. Currencies
23.4. Research Inquiries
23.5. The publisher

24. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Biogen Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc
  • MORE
The central nervous system drugs market consists sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that produce central nervous system drugs to treat brain and spinal cord diseases. This industry includes establishments that produce nervous system drugs, pain reducing analgesics, anti-Parkinson drugs to treat Parkinson’s disease, anticonvulsant anti-epileptics drugs to control epileptic seizures, anesthetics and other drugs such as muscle relaxants, antiemetics..

North America was the largest region in the global central nervous system drugs market, accounting for 43% of the market in 2018. Asia Pacific was the second largest region accounting for 24% of the global central nervous system drugs market. Africa was the smallest region in the global central nervous system drugs market.

Pharmaceutical companies are partnering with technology companies and incorporating wearables in clinical studies and for research and development of CNS disease treatments. These wearable devices make use of sensors to detect early symptoms of Parkinson’s disease such as tremors, slowness and stiffness in patients. Researchers use this data to gain insights about the disease and potential drug reactions, and thus reduce the time for trials by 30% to 50%.

For instance, in 2017, Michael J. Fox Foundation for Parkinson’s Research collaborated with specialty drugmaker Cynapsus Therapeutics and Intel to integrate wearable technology in a Phase-III clinical trial of APL-130277, an experimental drug for Parkinson’s disease. Biogen, a leading CNS drugmaker is using Fitbit, a smart wearable tracker, to better understand multiple sclerosis in patient studies, and the technology is expected to extend in Alzheimer’s disease research.
Note: Product cover images may vary from those shown
5 of 4
  • Biogen Inc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Pfizer Inc
  • Novartis AG
Note: Product cover images may vary from those shown
Adroll
adroll